Loading...
Sitagliptin
India Pharmaceutical Trade Intelligence
Who Supplies Sitagliptin to India from UNITED KINGDOM
India's sitagliptin imports from UNITED KINGDOM total $16.8K across 23 shipments from 10 foreign suppliers. AMSTERDAM PHARMA ( APTEKARX INC ) leads with $5.4K in import value; the top 5 suppliers together control 94.3% of this origin. Leading Indian buyers include AJANTA PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for sitagliptin — a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.
Top foreign suppliers (UNITED KINGDOM) — Ranked by import value
AMSTERDAM PHARMA ( APTEKARX INC ) is the leading Sitagliptin supplier from UNITED KINGDOM to India, with import value of $5.4K across 1 shipments. The top 5 suppliers — AMSTERDAM PHARMA ( APTEKARX INC ), PHARMACEUTICAL BUYERS, INC, ESPEE BIOPHARMA & FINECHEM LLC, BILCARE GCS LTD C/O MED FREIGHT SERVICES LTD, RX SOLUTION LIMITED — collectively account for 94.3% of total import value from this origin.
Top foreign suppliers (UNITED KINGDOM)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMSTERDAM PHARMA ( APTEKARX INC ) | $5.4K | 1 | 31.9% |
| 2 | PHARMACEUTICAL BUYERS, INC | $4.4K | 8 | 26.3% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $4.0K | 1 | 23.5% |
| 4 | BILCARE GCS LTD C/O MED FREIGHT SERVICES LTD | $1.5K | 2 | 8.7% |
| 5 | RX SOLUTION LIMITED | $656 | 3 | 3.9% |
| 6 | E PHARM LIMITED | $496 | 1 | 2.9% |
| 7 | ESPEE PHARMA (UK) LTD. | $240 | 1 | 1.4% |
| 8 | AJANTA PHARMA PHILIPPINES INC | $214 | 2 | 1.3% |
| 9 | EPHARM LIMITED | $4 | 2 | 0.0% |
| 10 | SYRI LIMITED T A THAME LABS B S GROUP | $2 | 2 | 0.0% |
Showing top 10 of 10 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED KINGDOM)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED | $9.5K | 4 | 56.7% |
| 2 | WATSON PHARMA PRIVATE LIMITED | $4.4K | 8 | 26.3% |
| 3 | THEMIS MEDICARE LIMITED | $1.5K | 2 | 8.7% |
| 4 | FDC LIMITED | $656 | 3 | 3.9% |
| 5 | MSN LABORATORIES PRIVATE LIMITED | $496 | 1 | 2.9% |
| 6 | M. J. BIOPHARM PRIVATE LIMITED | $240 | 1 | 1.4% |
| 7 | DR REDDYS LABORATORIES LIMITED | $4 | 2 | 0.0% |
| 8 | FUSION SCIENTIFIC LABORATORIES PRIVATE LIMITED | $2 | 2 | 0.0% |
Import Statistics
- Import Value
- $16.8K
- Shipments
- 23
- Foreign Suppliers
- 10
- Indian Buyers
- 8
- Avg. Shipment
- $732
Other Sitagliptin Import Origins
Related Analysis
Frequently Asked Questions — Sitagliptin Imports from UNITED KINGDOM
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Sitagliptin suppliers from UNITED KINGDOM to India?
The top Sitagliptin suppliers from UNITED KINGDOM to India include AMSTERDAM PHARMA ( APTEKARX INC ), PHARMACEUTICAL BUYERS, INC, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is AMSTERDAM PHARMA ( APTEKARX INC ) with import value of $5.4K USD across 1 shipments. India imported Sitagliptin worth $16.8K USD from UNITED KINGDOM in total across 23 shipments.
QHow much Sitagliptin does India import from UNITED KINGDOM?
India imported Sitagliptin worth $16.8K USD from UNITED KINGDOM across 23 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Sitagliptin from UNITED KINGDOM?
The main Indian buyers of Sitagliptin sourced from UNITED KINGDOM include AJANTA PHARMA LIMITED, WATSON PHARMA PRIVATE LIMITED, THEMIS MEDICARE LIMITED. The largest buyer is AJANTA PHARMA LIMITED with $9.5K in imports across 4 shipments.
QWhat is the total value of Sitagliptin imports from UNITED KINGDOM to India?
The total value of Sitagliptin imports from UNITED KINGDOM to India is $16.8K USD, across 23 shipments and 10 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED KINGDOM to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Sitagliptin.
- 2.Supplier/Buyer Matching: 10 foreign suppliers from UNITED KINGDOM and 8 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $16.8K aggregated from 23 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
10 suppliers, 8 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists